ETF Managers Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $507K | Buy |
6,131
+91
| +2% | +$7.53K | 0.02% | 450 |
|
2022
Q4 | $451K | Buy |
6,040
+220
| +4% | +$16.4K | 0.02% | 383 |
|
2022
Q3 | $481K | Buy |
5,820
+225
| +4% | +$18.6K | 0.02% | 438 |
|
2022
Q2 | $537K | Sell |
5,595
-2,714
| -33% | -$260K | 0.02% | 428 |
|
2022
Q1 | $973K | Buy |
8,309
+142
| +2% | +$16.6K | 0.02% | 284 |
|
2021
Q4 | $1.07M | Buy |
8,167
+387
| +5% | +$50.6K | 0.02% | 277 |
|
2021
Q3 | $883K | Buy |
7,780
+597
| +8% | +$67.8K | 0.02% | 293 |
|
2021
Q2 | $744K | Buy |
7,183
+2,076
| +41% | +$215K | 0.01% | 308 |
|
2021
Q1 | $423K | Buy |
5,107
+686
| +16% | +$56.8K | 0.01% | 520 |
|
2020
Q4 | $396K | Buy |
4,421
+392
| +10% | +$35.1K | 0.01% | 448 |
|
2020
Q3 | $316K | Buy |
4,029
+198
| +5% | +$15.5K | 0.01% | 452 |
|
2020
Q2 | $260K | Sell |
3,831
-615
| -14% | -$41.7K | 0.01% | 494 |
|
2020
Q1 | $291K | Buy |
4,446
+456
| +11% | +$29.8K | 0.01% | 318 |
|
2019
Q4 | $309K | Sell |
3,990
-6,507
| -62% | -$504K | 0.01% | 357 |
|
2019
Q3 | $760K | Sell |
10,497
-3,213
| -23% | -$233K | 0.03% | 220 |
|
2019
Q2 | $847K | Sell |
13,710
-7,173
| -34% | -$443K | 0.03% | 203 |
|
2019
Q1 | $1.33M | Sell |
20,883
-9,300
| -31% | -$593K | 0.07% | 140 |
|
2018
Q4 | $1.54M | Buy |
30,183
+27,786
| +1,159% | +$1.42M | 0.07% | 145 |
|
2018
Q3 | $139K | Sell |
2,397
-15,417
| -87% | -$894K | 0.01% | 312 |
|
2018
Q2 | $2.35K | Buy |
17,814
+15,582
| +698% | +$2.06K | 0.17% | 77 |
|
2018
Q1 | $101K | Buy |
2,232
+276
| +14% | +$12.5K | 0.01% | 278 |
|
2017
Q4 | $73K | Buy |
1,956
+276
| +16% | +$10.3K | 0.01% | 352 |
|
2017
Q3 | $61K | Buy |
1,680
+150
| +10% | +$5.45K | 0.01% | 242 |
|
2017
Q2 | $112K | Buy |
+1,530
| New | +$112K | 0.01% | 169 |
|
2016
Q4 | $18K | Sell |
600
-390
| -39% | -$11.7K | 0.08% | 56 |
|
2016
Q3 | $39K | Buy |
+990
| New | +$39K | 0.08% | 50 |
|
2016
Q1 | $54K | Buy |
+1,737
| New | +$54K | 0.04% | 120 |
|